ESMO President: What to watch for at ESMO 2021
17 Sep 2021
ESMO President: What to watch for at ESMO 2021
Clinical outcomes of relapsed/refractory multiple myeloma patients after BCMA-targeted CAR T therapy
Idecabtagene vicleucel for relapsed and refractory multiple myeloma
OncoAlert and ecancer weekly round up for August 16th - August 22nd, 2021
OncoAlert and ecancer weekly round up for August 2 - August 14, 2021
Myelodysplastic syndromes (MDS)
Predicting survival in NSCLC patients with poor performance status in resource-constrained settings
Updates in Hodgkin’s and non-Hodgkin lymphomas
Targeted therapy for breast cancer
Oncogenesis: Lung cancer
Triple negative breast cancer: OlympiA study
Pancreatic and Hepatobiliary Cancers